APON(300753) 证券时报网·2024-12-24 03:22Core Viewpoint - The company is actively involved in the development of brain-machine interface technologies and related products for the diagnosis and treatment of neurological disorders, leveraging advanced technologies such as artificial intelligence and flexible sensors. Group 1: Company Developments - The company has a stake in Changzhou Ruishen'an Medical Device Co., Ltd., which originated from a project at Tsinghua University's Microelectronics Institute focused on implantable neural stimulators [1] - Shenzhen Pengrui Brain Science Technology Co., Ltd. was established by the company this year, focusing on digital diagnosis and treatment products for neurological diseases, utilizing brain-machine interface and flexible sensor technologies [4] - Ruishen'an's products include a closed-loop neural stimulation system that is currently undergoing clinical trials for Parkinson's disease and epilepsy [5] Group 2: Technology and Product Focus - Pengrui is developing products based on non-invasive brain-machine interface technology, multimodal sensor technology, and artificial intelligence algorithms aimed at Attention Deficit Hyperactivity Disorder (ADHD) [2] - Ruishen'an's products represent an application of brain-machine interface technology, indicating a growing trend in the industry towards innovative treatment solutions for various brain disorders [3]